Iambic Therapeutics, Inc.

IAM chart

Iambic Therapeutics, Inc. news

• Iambic Therapeutics announces updated clinical data for IAM1363

  TipRanks · Oct 26, 8:10 AM EDT

• Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers

  Yahoo Finance · Oct 26, 8:00 AM EDT

• Iambic Therapeutics Inc. (IAM) Stock Price | Live Quotes & Charts | NASDAQ

  Timothy Sykes · Oct 26, 5:13 AM EDT

• Iambic Therapeutics, Inc. Estimates – NASDAQ:IAM

  TradingView · Oct 24, 12:05 AM EDT

• Biotech notches 31 IPOs already this year, with 4 more joining queue

  BioSpace · Oct 22, 10:19 AM EDT

• Scotiabank Remains a Buy on AbbVie (ABBV)

  The Globe and Mail · Oct 21, 7:40 AM EDT

• IPO Calendar for:

  Yahoo! Finance Canada · Oct 21, 3:52 AM EDT

• Iambic Therapeutics (IAM) Filed An IND For IAM217

  Yahoo Finance · Oct 18, 1:15 AM EDT

• Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?

  Yahoo Finance · Oct 17, 8:16 PM EDT

• Another Biotech IPO Pops on Rough Day for Broader Market

  Yahoo Finance · Oct 16, 1:46 PM EDT

• Cathie Wood-Backed Biotech IPO Pops in Debut

  Yahoo Finance · Oct 15, 1:38 PM EDT

• Iambic Announces Pricing of Initial Public Offering

  Yahoo Finance · Oct 14, 6:52 PM EDT

Iambic Therapeutics, Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-16
• S-1S-12026-09-21

About Iambic Therapeutics, Inc.

Ticker

IAM (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

San Diego, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1997038

Frequently asked questions